Logo image of OCI.AS

OCI NV (OCI.AS) Stock Fundamental Analysis

Europe - Euronext Amsterdam - AMS:OCI - NL0010558797 - Common Stock

3.05 EUR
-0.01 (-0.33%)
Last: 1/9/2026, 7:00:00 PM
Fundamental Rating

4

Overall OCI gets a fundamental rating of 4 out of 10. We evaluated OCI against 73 industry peers in the Chemicals industry. While OCI is still in line with the averages on profitability rating, there are concerns on its financial health. OCI is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

OCI had positive earnings in the past year.
OCI had a negative operating cash flow in the past year.
In multiple years OCI reported negative net income over the last 5 years.
Each year in the past 5 years OCI had a positive operating cash flow.
OCI.AS Yearly Net Income VS EBIT VS OCF VS FCFOCI.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

1.2 Ratios

OCI has a better Return On Assets (140.77%) than 100.00% of its industry peers.
OCI has a better Return On Equity (267.11%) than 100.00% of its industry peers.
Industry RankSector Rank
ROA 140.77%
ROE 267.11%
ROIC N/A
ROA(3y)41.09%
ROA(5y)25.43%
ROE(3y)77.65%
ROE(5y)49.16%
ROIC(3y)N/A
ROIC(5y)N/A
OCI.AS Yearly ROA, ROE, ROICOCI.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100 150 200

1.3 Margins

The Profit Margin of OCI (510.61%) is better than 100.00% of its industry peers.
OCI's Profit Margin has improved in the last couple of years.
OCI has a Gross Margin of 0.21%. This is amonst the worse of the industry: OCI underperforms 89.04% of its industry peers.
In the last couple of years the Gross Margin of OCI has declined.
Industry RankSector Rank
OM N/A
PM (TTM) 510.61%
GM 0.21%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y283.84%
PM growth 5YN/A
GM growth 3Y-81.68%
GM growth 5Y-54.61%
OCI.AS Yearly Profit, Operating, Gross MarginsOCI.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 200 300 400 500

3

2. Health

2.1 Basic Checks

OCI does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OCI has about the same amount of shares outstanding.
Compared to 5 years ago, OCI has more shares outstanding
OCI has a better debt/assets ratio than last year.
OCI.AS Yearly Shares OutstandingOCI.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
OCI.AS Yearly Total Debt VS Total AssetsOCI.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

Based on the Altman-Z score of 0.87, we must say that OCI is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.87, OCI is not doing good in the industry: 82.19% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.05 indicates that OCI is not too dependend on debt financing.
OCI's Debt to Equity ratio of 0.05 is amongst the best of the industry. OCI outperforms 90.41% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z 0.87
ROIC/WACCN/A
WACC8.08%
OCI.AS Yearly LT Debt VS Equity VS FCFOCI.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

2.3 Liquidity

OCI has a Current Ratio of 1.65. This is a normal value and indicates that OCI is financially healthy and should not expect problems in meeting its short term obligations.
OCI has a Current ratio of 1.65. This is comparable to the rest of the industry: OCI outperforms 49.32% of its industry peers.
OCI has a Quick Ratio of 1.60. This is a normal value and indicates that OCI is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.60, OCI is in the better half of the industry, outperforming 73.97% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.65
Quick Ratio 1.6
OCI.AS Yearly Current Assets VS Current LiabilitesOCI.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 1375.14% over the past year.
OCI shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 105.88% yearly.
Looking at the last year, OCI shows a small growth in Revenue. The Revenue has grown by 3.00% in the last year.
OCI shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -20.30% yearly.
EPS 1Y (TTM)1375.14%
EPS 3Y105.88%
EPS 5YN/A
EPS Q2Q%3950%
Revenue 1Y (TTM)3%
Revenue growth 3Y-46.36%
Revenue growth 5Y-20.3%
Sales Q2Q%-53.2%

3.2 Future

Based on estimates for the next years, OCI will show a very strong growth in Earnings Per Share. The EPS will grow by 60.21% on average per year.
The Revenue is expected to decrease by -14.70% on average over the next years. This is quite bad
EPS Next Y698.37%
EPS Next 2Y176.13%
EPS Next 3Y37.79%
EPS Next 5Y60.21%
Revenue Next Year-32.7%
Revenue Next 2Y-18.52%
Revenue Next 3Y-27.35%
Revenue Next 5Y-14.7%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
OCI.AS Yearly Revenue VS EstimatesOCI.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
OCI.AS Yearly EPS VS EstimatesOCI.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 0.15, the valuation of OCI can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of OCI indicates a rather cheap valuation: OCI is cheaper than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.19, OCI is valued rather cheaply.
A Price/Forward Earnings ratio of 9.57 indicates a reasonable valuation of OCI.
Based on the Price/Forward Earnings ratio, OCI is valued cheaply inside the industry as 91.78% of the companies are valued more expensively.
OCI's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.88.
Industry RankSector Rank
PE 0.15
Fwd PE 9.57
OCI.AS Price Earnings VS Forward Price EarningsOCI.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OCI.AS Per share dataOCI.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

OCI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
OCI's earnings are expected to grow with 37.79% in the coming years. This may justify a more expensive valuation.
PEG (NY)0
PEG (5Y)N/A
EPS Next 2Y176.13%
EPS Next 3Y37.79%

0

5. Dividend

5.1 Amount

No dividends for OCI!.
Industry RankSector Rank
Dividend Yield 0%

OCI NV

AMS:OCI (1/9/2026, 7:00:00 PM)

3.05

-0.01 (-0.33%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-13 2025-11-13
Earnings (Next)03-12 2026-03-12/amc
Inst Owners41.28%
Inst Owner ChangeN/A
Ins Owners8.46%
Ins Owner ChangeN/A
Market Cap644.65M
Revenue(TTM)975.10M
Net Income(TTM)4.98B
Analysts70
Price Target3.89 (27.54%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend12.96
Dividend Growth(5Y)N/A
DP84.62%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-35.82%
PT rev (3m)-46.25%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)14.8%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.18%
Revenue NY rev (3m)-3.34%
Valuation
Industry RankSector Rank
PE 0.15
Fwd PE 9.57
P/S 0.77
P/FCF N/A
P/OCF N/A
P/B 0.4
P/tB 0.41
EV/EBITDA N/A
EPS(TTM)20.21
EY662.62%
EPS(NY)0.32
Fwd EY10.44%
FCF(TTM)-1.07
FCFYN/A
OCF(TTM)-1.65
OCFYN/A
SpS3.95
BVpS7.55
TBVpS7.46
PEG (NY)0
PEG (5Y)N/A
Graham Number58.59
Profitability
Industry RankSector Rank
ROA 140.77%
ROE 267.11%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 510.61%
GM 0.21%
FCFM N/A
ROA(3y)41.09%
ROA(5y)25.43%
ROE(3y)77.65%
ROE(5y)49.16%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y283.84%
PM growth 5YN/A
GM growth 3Y-81.68%
GM growth 5Y-54.61%
F-Score4
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 244.07%
Cap/Sales 14.77%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.65
Quick Ratio 1.6
Altman-Z 0.87
F-Score4
WACC8.08%
ROIC/WACCN/A
Cap/Depr(3y)137.5%
Cap/Depr(5y)96.97%
Cap/Sales(3y)24.97%
Cap/Sales(5y)17.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1375.14%
EPS 3Y105.88%
EPS 5YN/A
EPS Q2Q%3950%
EPS Next Y698.37%
EPS Next 2Y176.13%
EPS Next 3Y37.79%
EPS Next 5Y60.21%
Revenue 1Y (TTM)3%
Revenue growth 3Y-46.36%
Revenue growth 5Y-20.3%
Sales Q2Q%-53.2%
Revenue Next Year-32.7%
Revenue Next 2Y-18.52%
Revenue Next 3Y-27.35%
Revenue Next 5Y-14.7%
EBIT growth 1Y44.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year113.34%
EBIT Next 3Y-24.1%
EBIT Next 5Y-4.61%
FCF growth 1Y-119.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-121.1%
OCF growth 3Y-68.92%
OCF growth 5Y-27.41%

OCI NV / OCI.AS FAQ

What is the ChartMill fundamental rating of OCI NV (OCI.AS) stock?

ChartMill assigns a fundamental rating of 4 / 10 to OCI.AS.


Can you provide the valuation status for OCI NV?

ChartMill assigns a valuation rating of 6 / 10 to OCI NV (OCI.AS). This can be considered as Fairly Valued.


What is the profitability of OCI stock?

OCI NV (OCI.AS) has a profitability rating of 4 / 10.


Can you provide the financial health for OCI stock?

The financial health rating of OCI NV (OCI.AS) is 3 / 10.


How sustainable is the dividend of OCI NV (OCI.AS) stock?

The dividend rating of OCI NV (OCI.AS) is 0 / 10 and the dividend payout ratio is 84.62%.